News

Fears that the EU will give up its involvement in health won’t go away. A big concern is that the next president of the Commission “might abolish” its responsibilities, says Austria’s director-general for health

Employees are lukewarm on new locations and a slow-down in work rate will mean less income. In the best case scenario Europe’s drugs regulator will take 2-3 years to get back to speed after leaving London.

Health insurers and pharma companies are striking pay-for-results deals under which rebates are offered if a drug does not perform as well in the real world as in clinical trials

Digital health start-up VitalSignum is on track to launch Beat2Phone, a small mobile device that detects arrhythmia by measuring the patient’s ECG, with the first production batch due to be on the market early next month.

Clinical trials are fundamental to the development of new treatments for cancer, but annual accrual to studies worldwide is low, at an estimated at three to five percent.